药品注册申请号:077574
申请类型:ANDA (仿制药申请)
申请人:FRESENIUS KABI USA
申请人全名:FRESENIUS KABI USA LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML No No AP 2006/11/27 2006/11/27 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/04/04 SUPPL-20(补充) Approval Labeling STANDARD
2024/04/04 SUPPL-17(补充) Approval Labeling STANDARD
2024/04/04 SUPPL-15(补充) Approval Labeling STANDARD
2015/04/20 SUPPL-5(补充) Approval Labeling
2011/10/14 SUPPL-11(补充) Approval Labeling
2011/07/15 SUPPL-10(补充) Approval Labeling
2011/07/08 SUPPL-8(补充) Approval Manufacturing (CMC)
2009/08/17 SUPPL-7(补充) Approval Labeling
2007/05/14 SUPPL-2(补充) Approval Labeling
2006/11/27 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PACLITAXEL 剂型/给药途径:INJECTABLE;INJECTION 规格:6MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
075184 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2002/01/25 TEVA PHARMS
075190 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2002/01/28 HIKMA
076131 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No Yes AP 2002/05/08 HOSPIRA
077574 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2006/11/27 FRESENIUS KABI USA
090130 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2009/12/09 ACTAVIS TOTOWA
207326 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2016/08/23 GLAND PHARMA LTD
205720 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2018/08/17 ACCORD HLTHCARE
213434 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2020/08/24 MSN
216874 001 ANDA PACLITAXEL PACLITAXEL INJECTABLE;INJECTION 6MG/ML Prescription No No AP 2022/10/20 ALEMBIC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database